InMed Pharmaceuticals Statistics
Total Valuation
INM has a market cap or net worth of $6.88 million. The enterprise value is $2.09 million.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INM has 4.46 million shares outstanding. The number of shares has increased by 365.07% in one year.
| Current Share Class | 3.31M |
| Shares Outstanding | 4.46M |
| Shares Change (YoY) | +365.07% |
| Shares Change (QoQ) | +2.37% |
| Owned by Insiders (%) | 7.53% |
| Owned by Institutions (%) | 9.73% |
| Float | 1.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.39 |
| Forward PS | n/a |
| PB Ratio | 0.74 |
| P/TBV Ratio | 1.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.11 |
| Quick Ratio | 2.35 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -402.21 |
Financial Efficiency
Return on equity (ROE) is -112.65% and return on invested capital (ROIC) is -66.23%.
| Return on Equity (ROE) | -112.65% |
| Return on Assets (ROA) | -54.61% |
| Return on Invested Capital (ROIC) | -66.23% |
| Return on Capital Employed (ROCE) | -116.20% |
| Weighted Average Cost of Capital (WACC) | 9.24% |
| Revenue Per Employee | $380,203 |
| Profits Per Employee | -$654,598 |
| Employee Count | 13 |
| Asset Turnover | 0.54 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.37% in the last 52 weeks. The beta is 0.97, so INM's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -59.37% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 1.31 |
| Relative Strength Index (RSI) | 61.35 |
| Average Volume (20 Days) | 77,522 |
Short Selling Information
The latest short interest is 134,109, so 3.00% of the outstanding shares have been sold short.
| Short Interest | 134,109 |
| Short Previous Month | 26,599 |
| Short % of Shares Out | 3.00% |
| Short % of Float | 12.63% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, INM had revenue of $4.94 million and -$8.51 million in losses. Loss per share was -$2.53.
| Revenue | 4.94M |
| Gross Profit | 1.71M |
| Operating Income | -8.04M |
| Pretax Income | -7.84M |
| Net Income | -8.51M |
| EBITDA | -7.83M |
| EBIT | -8.04M |
| Loss Per Share | -$2.53 |
Full Income StatementBalance Sheet
The company has $5.20 million in cash and $420,147 in debt, giving a net cash position of $4.78 million or $1.07 per share.
| Cash & Cash Equivalents | 5.20M |
| Total Debt | 420,147 |
| Net Cash | 4.78M |
| Net Cash Per Share | $1.07 |
| Equity (Book Value) | 6.89M |
| Book Value Per Share | 2.08 |
| Working Capital | 4.68M |
Full Balance SheetCash Flow
| Operating Cash Flow | -7.46M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 209,664 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.46M |
| FCF Per Share | -$1.67 |
Full Cash Flow StatementMargins
Gross margin is 34.53%, with operating and profit margins of -162.75% and -172.17%.
| Gross Margin | 34.53% |
| Operating Margin | -162.75% |
| Pretax Margin | -158.55% |
| Profit Margin | -172.17% |
| EBITDA Margin | -158.51% |
| EBIT Margin | -162.75% |
| FCF Margin | n/a |